Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 14/20 | 0.59 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.48 |
| ▸ | GNPAT | O15228 | 1/20 | 0.44 |
| ▸ | FNTA | P49354 | 2/20 | 0.44 |
| ▸ | FNTB | P49356 | 2/20 | 0.44 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.44 |
| ▸ | OTC | P00480 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13585280 | 1.00 | NOD1 (0.59) | NOD1FOLH1PTGS1GSTK1GNPAT | |
| SCHEMBL13585207 | 1.00 | NOD1 (0.59) | NOD1FOLH1PTGS1GSTK1GNPAT | |
| SCHEMBL1768815 | 0.89 | NOD1 (0.55) | NOD1FOLH1PTGS1GSTK1FNTA | |
| SCHEMBL22207952 | 0.89 | NOD1 (0.62) | NOD1FOLH1PTGS1GSTK1GNPAT | |
| SCHEMBL31137901 | 0.89 | NOD1 (0.62) | NOD1FOLH1PTGS1GSTK1GNPAT | |
| SCHEMBL20179364 | 0.88 | PTGS1 (0.64) | NOD1FOLH1PTGS1GSTK1FNTA | |
| SCHEMBL20539114 | 0.87 | NOD1 (0.47) | NOD1GNPATFNTAFNTBPGGT1B | |
| SCHEMBL18765407 | 0.87 | NOD1 (0.47) | NOD1GNPATFNTAFNTBPGGT1B | |
| Arginine SCHEMBL29425345 | 0.86 | NOD1 (0.77) | NOD1FNTAFNTB | |
| D-Glutamate SCHEMBL27891561 | 0.86 | NOD1 (0.69) | NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105399797-A | Primary sequences of 22 kinds of new ginseng polypeptides | LUO HAOMING | 2016-03-16 | — | — | CN | disclosed |